Pulse BiosciencesPLSE +3.42%31 PS Ratio is 2,580.00 as of Jun. 28, 2026, which is 130% above its 10-year median of 1,120.74. GuruFocus rates PLSE with a GF Score™ of 31/100. The stock has 3 warning signs investors should review. Among 805 Medical Devices & Instruments companies, Pulse Biosciences ranks worse than 99.75% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Pulse Biosciences's share price is $28.38.
Pulse Biosciences's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $0.01. Hence, Pulse Biosciences's PS Ratio for today is 2,580.00.
The historical rank and industry rank for Pulse Biosciences's PS Ratio or its related term are showing as below:
PLSE'
s PS Ratio Range Over the Past 10 Years
Min: 18.26 Med: 1120.74 Max: 19290
Current: 2580
During the past 12 years, Pulse Biosciences's highest PS Ratio was 19290.00. The lowest was 18.26. And the median was 1120.74.
PLSE's PS Ratio is ranked worse than 99.75% of 805
companies
in the Medical Devices & Instruments industry
Industry Median: 2.87
vs PLSE: 2580.00
Pulse Biosciences Inc revenue per share has been in decline over the past 3 years.
During the past 3 years, the average Revenue per Share Growth Rate was -37.00% per year.
During the past 12 years, Pulse Biosciences's highest 3-Year average Revenue per Share Growth Rate was -37.00% per year. The lowest was -37.00% per year. And the median was -37.00% per year.
Back to Basics: PS Ratio
Pulse Biosciences (NAS:PLSE) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Pulse Biosciences PS Ratio Related Terms
Pulse Biosciences PS Ratio Historical Data
* Premium members only.
The historical data trend for Pulse Biosciences's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Pulse Biosciences's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pulse Biosciences PS Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Pulse Biosciences's PS Ratio distribution charts can be found below:
* The bar in red indicates where Pulse Biosciences's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Pulse Biosciences's Share Price of today is $28.38. Pulse Biosciences's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.01.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Pulse Biosciences (PLSE) has a PS Ratio of 2,580.00 as of Jun. 28, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Pulse Biosciences and its competitors. This is 130% above median its historical median of 1,120.74. Over the past decade, Pulse Biosciences' PS Ratio has ranged from 18.26 to 19,290.00. According to the industry distribution chart, Pulse Biosciences ranks #803 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 99.8%.
Is Pulse Biosciences' PS Ratio too high?
Pulse Biosciences' current PS Ratio of 2,580.00 is 130% above median its 10-year median of 1,120.74. Over the past 10 years, this metric has ranged from a low of 18.26 to a high of 19,290.00. The Medical Devices & Instruments industry median PS Ratio is 2.87. Pulse Biosciences' value of 2,580.00 is 89795.5% above this industry median. Based on the distribution chart, Pulse Biosciences ranks #803 out of 805 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Pulse Biosciences has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Pulse Biosciences' PS Ratio compare to NNNN and STAA?
According to the Medical Devices & Instruments industry distribution chart, Pulse Biosciences ranks #803 out of 805 companies for PS Ratio. This places Pulse Biosciences in the lower half of its industry. The industry median PS Ratio is 2.87. Pulse Biosciences' value of 2,580.00 is 89795.5% above this benchmark. Historically, Pulse Biosciences' own PS Ratio has ranged from 18.26 to 19,290.00 over the past decade. While the company's 10-year median is 1,120.74 vs. the industry median of 2.87, Pulse Biosciences has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Devices & Instruments company?
The median PS Ratio among Medical Devices & Instruments companies is 2.87, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pulse Biosciences's current PS Ratio of 2,580.00 is 89795.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Pulse Biosciences and its competitors. For the Medical Devices & Instruments industry, the median PS Ratio is 2.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pulse Biosciences's current PS Ratio is 2,580.00, which is 130% above median its own 10-year median of 1,120.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pulse Biosciences stock overvalued right now?
Pulse Biosciences (PLSE) has a current PS Ratio of 2,580.00. The current PS Ratio is 2,580.00, which is 130% above median its 10-year median of 1,120.74 and 89795.5% above the Medical Devices & Instruments industry median of 2.87. Pulse Biosciences' overall GF Score™ is 31/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Pulse Biosciences (PLSE), the current PS Ratio is 2,580.00 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.
31GF Score
Get the complete analysis for PLSE
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PLSE has been successfully added to your 
